Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 4/2017

01-07-2017 | Original Article

Forearm bone mass predicts mortality in chronic hemodialysis patients

Authors: Lidija Orlic, Ivana Mikolasevic, Zeljka Crncevic-Orlic, Ivan Jakopcic, Josipa Josipovic, Drasko Pavlovic

Published in: Journal of Bone and Mineral Metabolism | Issue 4/2017

Login to get access

Abstract

We aim to determine the relationship between bone mineral density (BMD), measured by T- and Z–score, and mortality risk in hemodialysis (HD) patients. We also investigate which are the most suitable skeletal sites for predicting mortality rate. We analyzed the survival of 102 patients who had been treated with chronic HD according to BMD. Patients with a T-score ≤2.5 at the middle, ultradistal and proximal part of the forearm had a higher mortality risk than those with a T-score of −2.5 or higher. Furthermore, no statistically significant association was found between loss of bone mass at other measuring points—lumbar spine (anteroposterior orientation from L1–L4) and hip (neck, trochanter, intertrochanter, total and Ward’s triangle)—and mortality risk. We were also interested in exploring the relationship between Z-score at different skeletal regions and mortality risk. We found that patients with a Z-score of −1 or lower at all three parts of the forearm had a greater mortality risk. It is also worth noting that the Z-score at all three parts of the forearm was a more apparent predictor of mortality, compared to the T-score at the same skeletal regions. This empirical analysis showed that BMD assessments should be obtained at the forearm, due to the good predictability of this skeletal site regarding mortality of HD patients. Moreover, data concerning bone density should be reported as Z-scores.
Literature
1.
go back to reference Urena P, Poenaru-Bernard O, Ostertag A, Baudoin C, Solal-Cohen M, Cantor T et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331CrossRefPubMed Urena P, Poenaru-Bernard O, Ostertag A, Baudoin C, Solal-Cohen M, Cantor T et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331CrossRefPubMed
2.
go back to reference Chauhan V, Kelepouris E, Chauhan N, Vaid M (2012) Current concepts and management strategies in chronic kidney disease-mineral and bone disorder. South Med J 105:479–485CrossRefPubMed Chauhan V, Kelepouris E, Chauhan N, Vaid M (2012) Current concepts and management strategies in chronic kidney disease-mineral and bone disorder. South Med J 105:479–485CrossRefPubMed
3.
go back to reference Mott S (2009) Review article: bone density in patients with chronic kidney disease stages 4-5. Nephrology 14:395–403CrossRef Mott S (2009) Review article: bone density in patients with chronic kidney disease stages 4-5. Nephrology 14:395–403CrossRef
4.
go back to reference Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJD (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116–1120CrossRefPubMed Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJD (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116–1120CrossRefPubMed
5.
go back to reference Ambrus C, Marton A, Nemeth ZK, Mucsi I (2010) Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol 42:723–739CrossRefPubMed Ambrus C, Marton A, Nemeth ZK, Mucsi I (2010) Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol 42:723–739CrossRefPubMed
6.
go back to reference Ghosh AK (2004) Bone mineral density in the distal radius and increased risk of fractures in haemodialysis. Nephron Dial Transplant 19:1012–1013CrossRef Ghosh AK (2004) Bone mineral density in the distal radius and increased risk of fractures in haemodialysis. Nephron Dial Transplant 19:1012–1013CrossRef
7.
go back to reference Orlic L, Crncevic Z, Pavlovic D, Zaputovic L (2010) Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure. Ren Fail 32:300–308CrossRefPubMed Orlic L, Crncevic Z, Pavlovic D, Zaputovic L (2010) Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure. Ren Fail 32:300–308CrossRefPubMed
9.
go back to reference Cosman F, De Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRefPubMedPubMedCentral Cosman F, De Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRefPubMedPubMedCentral
11.
go back to reference Dolgos S, Hartmann A, Bonsnes E et al (2008) Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 22:462–468CrossRefPubMed Dolgos S, Hartmann A, Bonsnes E et al (2008) Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 22:462–468CrossRefPubMed
12.
go back to reference Negri AL, Barone R, Lombas C et al (2006) Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients. Hemodial Int 10:351–355CrossRefPubMed Negri AL, Barone R, Lombas C et al (2006) Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients. Hemodial Int 10:351–355CrossRefPubMed
13.
go back to reference Matsubara K, Suliman ME, Qureshi AR et al (2008) Bone mineral density in end-stage renal disease patients: association with waisting, cariovascular disease and mortality. Blood Purif 26:284–290CrossRefPubMed Matsubara K, Suliman ME, Qureshi AR et al (2008) Bone mineral density in end-stage renal disease patients: association with waisting, cariovascular disease and mortality. Blood Purif 26:284–290CrossRefPubMed
14.
go back to reference Park SH, Jia T, Qureshi AR, Bárány P, Heimbürger O, Larsson TE et al (2013) Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol 26:485–494CrossRefPubMed Park SH, Jia T, Qureshi AR, Bárány P, Heimbürger O, Larsson TE et al (2013) Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol 26:485–494CrossRefPubMed
15.
go back to reference KDIGO Clinical Practice Guideline for the Diagnosis (2009) Evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD–MBD). Kidney Int 76:1–140CrossRef KDIGO Clinical Practice Guideline for the Diagnosis (2009) Evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD–MBD). Kidney Int 76:1–140CrossRef
16.
go back to reference Obatake N, Ishimura E, Tsuchida T, Hirowatari K, Naka H, Imanishi Y et al (2007) Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy vitamin D. J Bone Miner Metab 25:74–79CrossRefPubMed Obatake N, Ishimura E, Tsuchida T, Hirowatari K, Naka H, Imanishi Y et al (2007) Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy vitamin D. J Bone Miner Metab 25:74–79CrossRefPubMed
17.
go back to reference Disthabanchong S, Jongjirasiri S, Adirekkiat S et al (2014) Low hip bone mineral density predicts mortality in maintained hemodialysis patients: a five year follow-up study. Blood Purif 37:33–38CrossRefPubMed Disthabanchong S, Jongjirasiri S, Adirekkiat S et al (2014) Low hip bone mineral density predicts mortality in maintained hemodialysis patients: a five year follow-up study. Blood Purif 37:33–38CrossRefPubMed
Metadata
Title
Forearm bone mass predicts mortality in chronic hemodialysis patients
Authors
Lidija Orlic
Ivana Mikolasevic
Zeljka Crncevic-Orlic
Ivan Jakopcic
Josipa Josipovic
Drasko Pavlovic
Publication date
01-07-2017
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 4/2017
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-016-0766-7

Other articles of this Issue 4/2017

Journal of Bone and Mineral Metabolism 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.